Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:21 AM
Ignite Modification Date:
2025-12-25 @ 1:21 AM
NCT ID:
NCT00414193
Eligibility Criteria:
Inclusion Criteria:
* Clinical information is collected by chart review of "case" and "control" patients. A "case" patient is defined as follows:
* One or more blood cultures are positive for E. cloacae, E. aerogenes, C. freundii, S. marcescens or M. morganii.
* The patient received piperacillin/tazobactam as the initial empiric therapy.
* The organism was susceptible to piperacillin/tazobactam.
* A "control" patient is defined as follows:
* One or more blood cultures are positive for E. cloacae, E. aerogenes, C. freundii, S. marcescens or M. morganii.
* The patient received a carbapenem or fluoroquinolone antimicrobial as the initial empiric therapy.
* The organism was susceptible to the empiric regimen.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00414193
Study Brief:
Protocol Section:
NCT00414193